Skip to main content

Table 6 Clinical characteristics of TM6SF2 rs58542926 T carriers and non-carriers in overall subjectsa

From: Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population

Characteristic CC (n = 794) CT + TT (n = 45) P Value
Age (yr) 54.60 ± 0.49 54.70 ± 0.48 0.863
BMI (kg/m2) 24.26 ± 1.40 24.33 ± 1.41 0.841
CAP (dB/m) 226.68 ± 28.88 243.42 ± 30.14 0.034
FPG (mmol/L) 4.97 ± 0.58 5.03 ± 0.81 0.741
TC (mmol/L) 5.63 ± 0.72 5.09 ± 0.85 0.175
TG (mmol/L) 1.93 ± 1.15 1.53 ± 1.22 0.029
LDL-C (mmol/L) 3.32 ± 0.60 3.16 ± 0.68 0.492
HDL-C (mmol/L) 1.31 ± 0.41 1.43 ± 0.42 0.429
AST (U/L) 39.66 ± 8.50 43.93 ± 7.90 0.042
ALT (U/L) 34.82 ± 10.50 36.57 ± 9.30 0.093
UA (μmol/L) 368.03 ± 74.49 357.46 ± 75.37 0.735
  1. Abbreviations: NAFLD non-alcoholic fatty liver disease, CRA colorectal adenoma, BMI body mass index, CAP controlled attenuation parameter, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, AST aspartate aminotransferase, ALT alanine aminotransferase, UA uric acid
  2. aValues are expressed as mean ± SD and compared by Student’s t-test